Prevent Blindness Declares Second Annual Fireworks Safety Awareness Week as June 28-July 4 to Educate on the Dangers of Fireworks

By Staff
Friday, June 24, 2022 12:24 AM CHICAGO—Prevent Blindness, the nation’s oldest nonprofit eye health and safety organization, has declared June 28-July 4, 2022 as the Second Annual Fireworks Safety Awareness Week, to help educate the public on the dangers of fireworks. During the week, Prevent Blindness will post messages on its various social media channels, as well as offer free shareable materials including fact sheets and social media graphics. Prevent Blindness has also issued its own Fireworks Position Statement,  according to an announcement from Prevent Blindness.

SightGlass Vision Spectacles Control Myopia Progression for Six- and Seven-Year-Olds, According to New Data Analysis

By Staff
Friday, June 24, 2022 12:21 AM PALO ALTO, CALIF.—Analysis of 24-month interim data from the pivotal “Cypress” clinical trial is offering increased hope for controlling myopia progression among young children, according to an announcement Thursday.

Ace Vision Group Appoints Elizabeth Yeu, MD, as Chief Strategic Advisor

By Staff
Tuesday, June 21, 2022 12:21 AM NEWARK, Del.—Ace Vision Group, a privately held U.S. ophthalmic medical device company developing Laser Microporation Therapeutic technologies to treat diseases of the aging eye, has appointed Elizabeth Yeu, MD to the role of chief strategic advisor.

All About Vision Launches Comprehensive Myopia Information Hub

By Staff
Monday, June 20, 2022 12:21 AM DALLAS—All About Vision (AAV), a leading online portal for vision and eyecare information, has launched a myopia information hub. Myopia has rapidly increased in prevalence worldwide, with an estimated 50 percent of the global population diagnosed by 2050, according to AAV.

Lensar Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System

By Staff
Monday, June 20, 2022 12:18 AM ORLANDO, Fla.—Lensar, Inc. (NASDAQ: LNSR), based here, announced that it has received U.S. Food and Drug Administration 510(k) clearance for its next-generation ALLY Adaptive Cataract Treatment System.

The Grolman Fitting System Was a Progressive Idea

By Andrew Karp
Friday, June 17, 2022 8:30 AM While researching and writing a feature article on presbyopia for the June issue of Vision Monday, I remembered a novel device called the Grolman Fitting System that was once used for fitting patients with progressive lenses. It was, excuse the pun, progressive for its time, though it has since been replaced with modern, digital technologies. Here’s a brief history of the device, drawn from an article I wrote about 25 years ago.

Regulatory Approvals Pave Way for J&J Vision’s Multinational Launch of Acuvue Oasys Max 1-Day Contacts

By Staff
Thursday, June 16, 2022 12:24 AM JACKSONVILLE, Fla.—Johnson & Johnson Vision said it has received U.S. Food & Drug Administration (FDA) clearance, Health Canada approval and completed CE Mark activities for its latest contact lens innovation, Acuvue Oasys Max 1-Day and Acuvue Oasys Max 1-Day Multifocal.

Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

By Staff
Wednesday, June 15, 2022 12:21 AM SEATTLE, BOSTON and TOKYO—Aurion Biotech has appointed Michael Goldstein, MD, MBA, as president and chief medical officer.

Vyluma and Laboratoires Théa Enter Licensing Agreement for the Registration and Commercialization of NVK002 in Canada, Mexico, and Select South American Countries

By Staff
Wednesday, June 15, 2022 12:18 AM BRIDGEWATER, N.J—Vyluma, Inc., a biopharmaceutical company developing multiple assets in the ophthalmic space for the treatment of refractive errors, and Laboratoires Théa announced that they have recently entered into an exclusive licensing agreement for the registration and commercialization of NVK002 in Canada, Mexico, and select South American Countries.

Consumer Interest in Vision Benefits Is Rising, Led by Virtual Eyecare Options, Versant Study Finds

By Staff
Tuesday, June 14, 2022 12:27 AM BALTIMORE—Consumer opinions of the value of vision care as part of whole-body health are rising, according to the results of Versant Health’s newly released third annual Vision Wellness Study. The study also found that more people agree that the ability to identify both eye diseases and chronic health conditions are highly valuable services offered by eye doctors. Additionally, Versant found that the use of virtual eyecare options—including telemedicine, tech-enabled communication, and online eyewear shopping—have both increased year-over year and influence consumer's insurance benefits decisions.

CooperVision Says New MiSight 1 day Prescriber Data Signals Myopia Control 'Confidence' Among ECPs

By Staff
Friday, June 10, 2022 12:18 AM SAN RAMON, Calif.—CooperVision, a leader in myopia management, has announced new data that the company said demonstrates how certified U.S. eyecare practices have embraced MiSight 1 day contact lenses for myopia control.

First-of-its-Kind Study Finds AI Screenings Improve Eyecare Access in Sub-Saharan Africa

By Staff
Thursday, June 9, 2022 12:21 AM NEW YORK—Orbis International announced new research findings demonstrating that diabetic retinopathy screenings supported by artificial intelligence (AI) enhanced patients' speed and uptake of referral services in Rwanda, which can help reduce vision loss due to diabetes in the region.

The Vision Council Promotes National Sunglasses Day, Taking Place on Monday, June 27

By Staff
Wednesday, June 8, 2022 12:15 AM ALEXANDRIA, Va.—The Vision Council is promoting the importance of ultraviolet (UV)-protective eyewear through the celebration of National Sunglasses Day, taking place on Monday, June 27, 2022.

Football Star Cooper Kupp to Promote Alcon’s Pataday Eye Allergy Drops

By Staff
Tuesday, June 7, 2022 12:21 AM FORT WORTH, Texas—Alcon has formed a partnership with Cooper Kupp, professional football wide receiver and MVP of the “Big Game,” to share his experience with eye allergies and help other eye allergy sufferers find relief with Pataday Once Daily Relief Extra Strength.